Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ampion in osteoarthritis of the knee (STRIDE)
NCT02242435Phase 3Completed
- Sponsor
- Ampio Pharmaceuticals, Inc.
- Start
- Sep 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of aspartyl-alanyl-diketopiperazine in knee osteoarthritis (OA), sponsored by Ampio Pharmaceuticals, Inc.. Started Sep 2014; status: completed.
02
Drugs
aspartyl-alanyl-diketopiperazine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02242435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02242435.